Unresolved toxicity (i.e., > grade  or above baseline) due to previously administered agents; exception includes: subjects with =< grade  neuropathy are eligible for the study
Baseline neuropathy of > grade 
SAFETY RUN-IN: Patients with baseline grade  neuropathy
Neurosensory neuropathy > grade  at baseline.
Patient has not recovered (i.e., =< grade  or baseline) from adverse events due to prior anti-cancer therapy;\r\n* Note: patients with =< grade  neuropathy are eligible
Patients with any baseline grade  neuropathy
Only for subjects enrolled in Arm  - Neratinib and palbociclib: any prior neuropathy should be back to baseline or grade .
Grade  baseline neuropathy
Diabetic neuropathy (any grade)
Patient has baseline neuropathy of >= grade 
Grade II or greater neuropathy at baseline
Baseline neuropathy > grade 
Patient has baseline neuropathy of > grade 
Neuropathy uropathy europathy Nemediastinal DLBCL.
Neurosensory neuropathy ? grade  at baseline.
Patients with symptomatic neuropathy
Previous diagnosis of diabetic neuropathy or peripheral neuropathy from any cause
Neurosensory neuropathy ? grade  at baseline
Significant neuropathy >= grade  or grade  neuropathy with pain at baseline
Significant neuropathy >= grade  or grade  neuropathy with pain at baseline
Patient has baseline neuropathy of >= grade 
Significant neuropathy >= grade  or grade  neuropathy with pain at baseline
Clinical evidence of neuropathy
Significant neuropathy >= grade  at baseline
Patients with any neuropathy.
Neuropathy >= grade  (moderate neuropathy that limits instrumental activities of daily living)
Previous diagnosis of diabetic neuropathy or peripheral neuropathy from any cause
Neuropathy: no baseline neuropathy grade > 
History of diabetic neuropathy or neuropathy related to human immunodeficiency virus (HIV)
Known diabetic neuropathy
History of diabetic neuropathy or neuropathy related to human immunodeficiency virus (HIV)
Diabetic neuropathy or other neurological conditions
Greater than Grade  neuropathy or ? Grade  neuropathy with pain at baseline, regardless of whether or not the patient is currently receiving medication